Fig 1.
Flow diagram of study selection.
Table 1.
Study characteristics.
Table 2.
Primary outcomes.
Fig 2.
Forest plot of the efficacy of recombinant herpes zoster vaccine on herpes zoster incidence.
Fig 3.
Pooled humoral immunogenicity for recombinant herpes zoster vaccine compared with control arm at one month after the last dose.
Fig 4.
Pooled cellular immunogenicity for recombinant herpes zoster vaccine compared with control arm at one month after the last dose.
Fig 5.
Forest plot of the effect of recombinant herpes vaccine compared with control arm on local and general adverse effects.